financetom
Business
financetom
/
Business
/
Newell Brands Stock Retreats After 40% Q2 Surge, Lagging Small and Mid-Cap Peers, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newell Brands Stock Retreats After 40% Q2 Surge, Lagging Small and Mid-Cap Peers, UBS Says
Oct 18, 2024 12:54 PM

03:35 PM EDT, 10/18/2024 (MT Newswires) -- Newell Brands' ( NWL ) stock "pulled back" after a 40% surge following a strong Q2, now trailing small- and mid-capitalization companies within the household and personal care peers by 21% since late July, UBS said in a note emailed Friday.

Investor sentiment appears neutral to mixed, with many focusing on the uncertain timeline for a return to positive revenue growth, UBS said.

"[Newell] is scheduled to report [Q3] earnings on Friday 10/25 before the open," UBS said, adding that it projects earnings per share of $0.15, which is slightly below the Visible Alpha/FactSet consensus.

"While we believe that [Newell's] updated guidance is more than achievable, we agree that visibility remains quite limited around core sales growth trajectory heading into FY25, particularly for the Outdoor & Recreation segment which is still quite challenged," UBS said.

Newell raised its 2024 guidance after a strong Q2 and now expects core sales declines of -4% to -3% and net sales down -7% to -6%, with an adjusted operating profit margin of 8% to 8.2% and EPS of $0.60 to $0.65, the note said. "Our conversations would suggest that most investors have confidence in the company's ability to deliver on its updated guidance at this stage of the year," it added.

UBS has a neutral rating on Newell Brands ( NWL ) with a 12-month price target of $8.50.

Shares of Newell Brands ( NWL ) were up 2.1% in recent Friday trading.

Price: 7.84, Change: +0.16, Percent Change: +2.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GreenPower Shares Up 2.9% in U.S. Pre-market on First Bus Deliveries to West Virginia
GreenPower Shares Up 2.9% in U.S. Pre-market on First Bus Deliveries to West Virginia
Mar 20, 2025
09:08 AM EDT, 03/20/2025 (MT Newswires) -- GreenPower Motor ( GP ) rose 2.9% at last look Thursday in Nasdaq pre-market trading as the company announced the delivery of the first four all-electric, zero-emission school buses to its West Virginia dealer for the Kanawha County School District. The deliveries were made under round two funding of the Environmental Protection Agency's...
Autonomix Medical Granted US Patent for Catheter-Based Technology; Shares Up 10% Pre-Bell
Autonomix Medical Granted US Patent for Catheter-Based Technology; Shares Up 10% Pre-Bell
Mar 20, 2025
09:17 AM EDT, 03/20/2025 (MT Newswires) -- Autonomix Medical ( AMIX ) shares were up more than 10% in recent premarket activity Thursday after the medical device company said the US Patent and Trademark Office had granted it a patent for its proprietary catheter-based technology used to collect and process sensing data for real-time physiological monitoring. The company said the...
Sector Update: Consumer Stocks Mixed Pre-Bell Thursday
Sector Update: Consumer Stocks Mixed Pre-Bell Thursday
Mar 20, 2025
09:12 AM EDT, 03/20/2025 (MT Newswires) -- Consumer stocks were mixed pre-bell Thursday as the Consumer Staples Select Sector SPDR Fund ( XLP ) was up 0.1% and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) was 0.7% lower recently. PDD Holdings ( PDD ) shares declined by over 3% after the company reported Q4 revenue that missed...
Akari Therapeutics Names Abizer Gaslightwala CEO
Akari Therapeutics Names Abizer Gaslightwala CEO
Mar 20, 2025
09:13 AM EDT, 03/20/2025 (MT Newswires) -- Akari Therapeutics ( AKTX ) said Thursday that it has appointed Abizer Gaslightwala as president and chief executive officer, starting April 21. Gaslightwala was most recently senior vice president and franchise head for US Oncology at Jazz Pharmaceuticals (JAZZ), Akari said. Gaslightwala was appointed to Akari's board in December, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved